Crónicas de autores

Sebastián Carranza Lira *

Autor invitado por SIIC

Se presenta la experiencia en la utilización de dosis bajas y ultrabajas de terapia estrogénica

DOSIS BAJAS Y ULTRABAJAS DE ESTROGENOS EN EL CLIMATERIO

Las dosis ultrabajas de terapia estrogénica ofrecen una alternativa para el control de los síntomas climatéricos.

*Sebastián Carranza Lira
describe para SIIC los aspectos relevantes de su trabajo
LOW AND ULTRA LOW-DOSE ESTROGEN THERAPY FOR CLIMACTERIC SYMPTOM CONTROL - PRELIMINARY REPORT
International Journal of Fertility and Women´s Medicine,
51(4):171-175 Jul, 2006

Esta revista, clasificada por SIIC Data Bases, integra el acervo bibliográfico
de la Biblioteca Biomédica (BB) SIIC.

Institución principal de la investigación
*, México D.F., México, México D.F., México
Profundizar
Imprimir nota
Comprar este artículo
Otros artículos escogidos
Referencias bibliográficas
1. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA 288:321-33, 2002.
2. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 362:419-27, 2003.
3. Burger H, Archer D, Barlow D, et al. Practical recommendations for hormone replacement therapy on the peri- and postmenopause. Climacteric 7:210-6, 2004.
4. Ettinger B, Genant HK, Cann CE. Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med 104:40-4, 1987.
5. Gambacciani M, Ciaponi M, Cappagli B, Genazzani AR. Effects of low-dose continuous combined estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density and metabolism in postmenopausal women. Am J Obstet Gynecol 185:1180-5, 2001.
6. Rebar RW, Trabal J, Mortola J. Low-dose esterified estrogens (0.3 mg/day): long-term and short-term effects on menopausal symptoms and quality of life in postmenopausal women. Climacteric 3:176-82, 2000.
7. Utian WH, Burry KA, Archer DF, et al. Efficacy and safety of low, standard, and high dosages of an estradiol transdermal system (Esclim) compared with placebo on vasomotor symptoms in highly symptomatic menopausal patients. Am J Obstet Gynecol 181:71-9, 1999.
8. Marx P, Schade G, Wilbourn S, Blank S, Moyer DL, Nett R. Low-dose (0.3 mg) synthetic conjugated estrogens A is effective for managing atrophic vaginitis. Maturitas 47:47-54, 2003.
9. Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate. Fertil Steril 75:1065-79, 2001.
10. Prestwood KM, Kenny AM, Kleppinger A, Kuldorff M. Ultralow-dose micronized 17ß-estradiol and bone density and bone metabolism in older women. JAMA 290:1042-8, 2003.
11. Ettinger B. Unopposed ultra-low-dose estradiol: A new approach to osteoporosis prevention. J Fam Pract 53(Suppl):17-9 2004.
12. Archer DF, Dorin M, Lewis V, Schneider DL, Pickar JH. Effects of lower doses of conjugated estrogens and medroxyprogesterone acetate on endometrial bleeding. Fertil Steril 75:1080-7, 2001.
Otros artículos de Sebastián Carranza Lira

Jackson VP, San Martín JA, Secrest RJ, McNabb M, Carranza Lira S, Figueroa Casas P, Fernandes CE, Romaguera J. Comparison of the effect of raloxifene and continuous-combined hormone therapy on mammographic breast density and breast tenderness in postmenopausal women. Am J Obstet Gynecol 188(2):389-94, 2003.'Carranza Lira S, Reyes Razo BP, Chan Verdugo R. SUMEVA, a new system of climacteric symptom evaluation, and its correlation with FSH and estradiol levels. Int J Fertil Womens Med 51(3):140-4, 2006.'Carranza Lira S, Velasco Díaz G, Olivares A, Chan Verdugo R, Herrera J. Correlation of Kupperman's index with estrogen and androgen levels, according to weight and body fat distribution in postmenopausal women from Mexico City. Int J Fertil Womens Med 51(2):83-8, 2006.'Carranza Lira S, MacGregor-Gooch AL. Differences in vaginal dryness according to hormone therapy schedule using pH test strip in two groups of postmenopausal women. Int J Fertil Womens Med 49(2):88-90, 2004.'Carranza Lira S, Mera JP. Influence of number of pregnancies and total breast-feeding time on bone mineral density. Int J Fertil Womens Med 47(4):169-71, 2002.'Carranza Lira S, Rosas M, Murillo A, Martínez N, Santos J. Osteoporosis in postmenopausal women (Mexico City): 2. Validation of a predictive clinical index. Int J Fertil Womens Med 47(1):26-31, 2002.'Carranza Lira S, Rosas M, Murillo A, Martínez N, Santos J. Osteoporosis in postmenopausal women (Mexico City): 1. Risk factors. Int J Fertil Womens Med 47(1):22-5, 2002.'Carranza Lira S, Garduno Hernández MP, Caisapanta DA, Aparicio H. Evaluation of mastodynia in postmenopausal women taking hormone therapy. Int J Gynaecol Obstet 89(2):158-9, 2005.'Maia H, Albernaz MA, Baracat EC, Barbosa IC, Bossemeyer R, Bueno AH, Campos OG, Carranza Lira S, Casas PF, Castro AM, De Lima GR, De Melo NR, Fernandes CE, González JS, Larrañaga FE, Siseles N, Uribe AM, Vilchez RM, Latin American Expert Panel Latin American position on the current status of hormone therapy during the menopausal transition and thereafter. Maturitas 55(1):5-13, 2006.

Para comunicarse con Sebastián Carranza Lira mencionar a SIIC como referencia:
scarranzal@mexis.com

Autor invitado
27 de febrero, 2007
Descripción aprobada
7 de abril, 2007
Reedición siicsalud
7 de junio, 2021

Acerca del trabajo completo
DOSIS BAJAS Y ULTRABAJAS DE ESTROGENOS EN EL CLIMATERIO

Título original en castellano
Dosis bajas y ultra-bajas de terapia estrogEnica para el control de los sIntomas climatEricos, reporte preliminar

Autores
Sebastián Carranza Lira1, Ana Luz Mac Gregor Gooch2, Guillermina Velasco Díaz3, Jacqueline Solano4, Angélica Arzola Paniagua5
1 Médico, Instituto Mexicano del Seguro Social, México D.F., México, Director de Educación e Investigación
2 Médico, Instituto Mexicano del Seguro Social (IMSS), México D.F., México, Médico Adscrito
3 Médico, Instituto Mexicano del Seguro Social (IMSS), Médico Adscrito
4 Médico
5 Médico, Laboratorio Senosiain, México D.F., México

Acceso a la fuente original
International Journal of Fertility and Women´s Medicine
http://www.wffh.org/affiliation.asp

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades
     


ua40317

Copyright siicsalud © 1997-2024 ISSN siicsalud: 1667-9008